GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allegra Medical Technologies Ltd (ASX:AMT) » Definitions » Total Assets

Allegra Medical Technologies (ASX:AMT) Total Assets : A$0.44 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Allegra Medical Technologies Total Assets?

Allegra Medical Technologies's Total Assets for the quarter that ended in Dec. 2023 was A$0.44 Mil.

During the past 12 months, Allegra Medical Technologies's average Total Assets Growth Rate was -93.90% per year. During the past 3 years, the average Total Assets Growth Rate was -21.80% per year. During the past 5 years, the average Total Assets Growth Rate was -9.90% per year. During the past 10 years, the average Total Assets Growth Rate was -5.90% per year.

During the past 13 years, Allegra Medical Technologies's highest 3-Year average Total Assets Growth Rate was 18.90%. The lowest was -28.20%. And the median was -2.10%.

Total Assets is connected with ROA %. Allegra Medical Technologies's annualized ROA % for the quarter that ended in Dec. 2023 was -172.21%. Total Assets is also linked to Revenue through Asset Turnover. Allegra Medical Technologies's Asset Turnover for the quarter that ended in Dec. 2023 was 0.29.


Allegra Medical Technologies Total Assets Historical Data

The historical data trend for Allegra Medical Technologies's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allegra Medical Technologies Total Assets Chart

Allegra Medical Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.79 6.85 6.34 5.61 2.91

Allegra Medical Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.57 5.61 5.34 2.91 0.44

Allegra Medical Technologies Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Allegra Medical Technologies's Total Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Assets=Total Equity (A: Jun. 2023 )+Total Liabilities (A: Jun. 2023 )
=-1.499+4.412
=2.91

Allegra Medical Technologies's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=-1.613+2.053
=0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allegra Medical Technologies  (ASX:AMT) Total Assets Explanation

Total Assets is connected with ROA %.

Allegra Medical Technologies's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-2.888/( (2.913+0.441)/ 2 )
=-2.888/1.677
=-172.21 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Allegra Medical Technologies's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=0.48/( (2.913+0.441)/ 2 )
=0.48/1.677
=0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Allegra Medical Technologies Total Assets Related Terms

Thank you for viewing the detailed overview of Allegra Medical Technologies's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Allegra Medical Technologies (ASX:AMT) Business Description

Traded in Other Exchanges
N/A
Address
18-20 Orion Road, Level 8, Lane Cove West, Sydney, NSW, AUS, 2066
Allegra Medical Technologies Ltd is engaged in the research, product development, and manufacturing of medical devices including prosthetic implant tools. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and ulna heads, compression screws, distal radius systems, and hand fracture systems; hip stems and heads, CSF cups, and evolution and resurfacing hip products; and knee replacement systems among others. It operates in two segments Orthopaedics Division, which derives the majority of its revenue sells and distributes its portfolio of medical device products. Innovation Division which invests resources into the development and commercialization of new products to take to market.